期刊文献+

泌尿系感染病原菌分布及耐药性监测 被引量:4

Drug resistance of pathogens in urinary system infection
下载PDF
导出
摘要 目的 了解我院泌尿系感染病原菌的分布现状及体外耐药性,为临床提供诊断与治疗依据.方法 采用全自动微生物分析仪ATB Expression及配套试剂,对我院2005年1月1日~2006年6月30日的住院及门诊患者尿培养分离出的561株病原菌进行细菌鉴定和体外耐药性监测.结果 大肠埃希菌是引发泌尿系感染的主要病原菌,占42.1%;其次为肠球菌属(14.2%)、直菌(13.7%)、凝固酶阴性葡萄球菌(9.1%)、肺炎克雷伯菌(4.5%)、奇异变形杆菌(2.9%)及铜绿假单胞菌(2.1%);大肠埃希菌和肺炎克雷伯菌产ESBLs株检出率分别为37.7%和40.0%,耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)和高水平庆大霉素耐药肠球菌(HLGR)检出率分别为66.7%和72.5%;体外耐药监测表明;肠杆菌科细菌对碳青酶烯类保持100%敏感性,对β-内酰脑酶抑制剂复合物和阿米卡星敏感性较强(76%),对其他抗菌药物耐药率较高;革兰阳性球菌耐药情况也相当严重,但尚未发现耐万古霉素菌株.结论 泌尿系感染最主要病原菌为大肠埃希菌,假丝酵母菌分离率显著上升;病原菌耐药率呈上升趋势,临床医师应积极送检,根据尿培养结果合理选用抗菌药物进行治疗. Objective To investjgate the distribution and drug resistance of pathogensin urinary system in fection.Mtethods A total of 561 pathogen strains in urinary systeminfection from inpatjents and outpatients in our hospital from Jan 2006 to June 2006 wereidentified and the drug resistance test was preformed by ATB expression.Results Among these pathogens,Eseherichia coli rated the top one(42.1%),followed by Enterococ cus(14.2%),fungus(13.7%),coagulase negative Staphylococcus(9.1%),Klebsiella pneumoniae(4.5%),P.mirabilis(2.9%) and Pseudomonas aeruginosa(2.1%).The incidence of MRCNS,HLGR,ESBL-prodneINg E.coli and K.pneumoni AE,were 66.7%,72.5%,37.7% and 40.0% respectively.The result of drug resistanee suggested that Entetobacteriaceaebe resistantto several ant ibiotics,but still sensitive to carbapenems(100%),bata-lactamase inhibtor combinations and amikacin(≥76%).g+ Cocei were also,showed very serious drugresistance,butstill sensilive to vancomycin(100%).Conclusions E.coli is the main infectious bacterium in urinary system infection.Rational use of antibioties should be earried out a ccording to urine culture results.
出处 《医学检验与临床》 2006年第6期12-14,共3页 Medical Laboratory Science and Clinics
  • 相关文献

参考文献7

二级参考文献35

  • 1金少鸿.抗生素在食用动物中的应用以及食源性疾病对人类健康的影响[J].中华微生物学和免疫学杂志,2001,21(S1):25-25. 被引量:8
  • 2李立津,官兰.氟喹诺酮等抗菌药物体外抗菌活性及其临床意义[J].中华内科杂志,1993,32(3):148-151. 被引量:1
  • 3郭文学,官兰,吴瑾,刘德孟,宋诗铎,胡文芝.五种氟喹诺酮类药物对临床分离致病菌的体外抗菌活性[J].天津医药,1996,24(10):611-613. 被引量:1
  • 4叶应妩 王毓三.全国临床检验操作规程[S].[S].南京:东南大学出版社,1997.474-486. 被引量:1
  • 5Clifford ML, Feng JC, Hsiu JL, et al. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distince selective pressures[J]. Antimicrob Agents Chemother, 2001, 45: 3084-3091. 被引量:1
  • 6Rahal JJ, Urban C, Segal-Manrer S. Nosocomial antibiotic resistance in multiple Gram-negative species : experience at one hospital with squeezing the resistance balloon at multiple sites[J]. CID, 2002, 34: 499-503. 被引量:1
  • 7Bradford PA. Extended-spectrum β-lactamases in 21st Century: characterization, epidemiology and detection of this important resistance threat[J]. Clin Microbiol Rev, 2001, 14: 933-951. 被引量:1
  • 8张险峰 陆玉霞 等.产超广谱β-内酰胺酶细菌对17种抗生素的耐药分析[J].临床检验杂志,2000,18(6):376-376. 被引量:7
  • 9Tseng CY,Liu PY,Wu WL,et al.Comparison of detection of extended-spectrum beta-lactamases by agar dilution method,E-test ESBL screen and double disk test[J].J Microbiol Immunol Infect 1998,31(2):90-94. 被引量:1
  • 10Sirot D.Extended-spectrum plasmid-mediated β-lactamases[J].J Antimicrob Chemot her,1996,(SupplA):19-34. 被引量:1

共引文献385

同被引文献37

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部